-
1.INTERFERON-BETA FOR USE AS MONOTHERAPY OR IN COMBINATION WITH OTHER CANCER THERAPIES 审中-公开
标题翻译: 干扰素作为单独使用或与其他癌症治疗组合使用公开(公告)号:US20120082647A1
公开(公告)日:2012-04-05
申请号:US13247556
申请日:2011-09-28
CPC分类号: A61K38/215 , A61K31/166 , A61K31/337 , A61K31/4188 , A61K31/436 , A61K31/44 , A61K39/3955 , A61K45/06 , A61K47/60 , A61K2039/505 , A61K2300/00 , C07K16/22 , C07K2317/24 , C07K2317/76
摘要: This description relates to the use of a polymer-conjugated interferon-beta as monotherapy or in combination with other cancer therapies.
摘要翻译: 该描述涉及聚合物缀合的干扰素-β作为单一疗法或与其它癌症治疗组合的用途。